genprowebdirectory
Skip to content
Facebook
LinkedIn
RSS
Twitter/X
YouTube
GEN Edge
Featured News
Multimedia
Content
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Toggle Search
Search for:
Search
Search
Toggle Mobile Menu
Toggle Search
×
GEN Edge
Expand submenu
Featured News
Multimedia
Content
Expand submenu
News
Insights
Topics
Expand submenu
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Expand submenu
Browse Issues
Subscribe
Multimedia
Expand submenu
Summits & Spotlights
Webinars
GEN Live
Learning Labs
Podcasts
Videos
Resources
Expand submenu
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
Expand submenu
GEN Biotechnology
Re:Gen Open
New Products
Subscribe
Expand submenu
Get GEN Magazine
Get GEN eNewsletters
×
Search for:
Search
Search
Home
>
Multimedia
>
Podcasts
>
John Sterling talks with Bruce H. Littman, M.D., Vice President and Head, Global Translational Medicine, Pfizer Global Research and Development about translational medicine.
John Sterling talks with Bruce H. Littman, M.D., Vice President and Head, Global Translational Medicine, Pfizer Global Research and Development about translational medicine.
April 20, 2006
/wp-content/uploads/2018/09/gc_22.mp3
Podcasts
Resources
Cell biology
Cellular, Molecular and Developmental Biology
Research and development
Research resources
